Global Disposable Insulin Pumps Pipeline Product Landscape Report 2021 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Disposable Insulin Pumps - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.

"Disposable Insulin Pumps - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Disposable Insulin Pumps pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Disposable Insulin Pumps are the disposable insulin delivery device that administers programmed doses of insulin for diabetes management.

Scope

• Extensive coverage of the Disposable Insulin Pumps under development
• The report reviews details of major pipeline products which includes product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Disposable Insulin Pumps and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Disposable Insulin Pumps under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Disposable Insulin Pumps Overview

3 Products under Development

3.1 Disposable Insulin Pumps - Pipeline Products by Stage of Development

3.2 Disposable Insulin Pumps - Pipeline Products by Territory

3.3 Disposable Insulin Pumps - Pipeline Products by Regulatory Path

3.4 Disposable Insulin Pumps - Pipeline Products by Estimated Approval Date

4 Disposable Insulin Pumps - Pipeline Products under Development by Companies

4.1 Disposable Insulin Pumps Companies - Pipeline Products by Stage of Development

4.2 Disposable Insulin Pumps - Pipeline Products by Stage of Development

5 Disposable Insulin Pumps Companies and Product Overview

5.1 Andain, Inc Company Overview

5.1.1 Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview

5.2 Debiotech SA Company Overview

5.2.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview

5.3 MedSolve Technologies, Inc. Company Overview

5.3.1 MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.4 Qlibrium Inc Company Overview

5.4.1 Qlibrium Inc Pipeline Products & Ongoing Clinical Trials Overview

5.5 SFC Fluidics LLC Company Overview

5.5.1 SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview

5.6 Thermalin Inc Company Overview

5.6.1 Thermalin Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Disposable Insulin Pumps- Recent Developments

6.1 May 06, 2021: Insulet Reports First Quarter 2021 Revenue Increase of 27% Year-Over-Year

6.2 Apr 05, 2021: Insulet to Announce First Quarter 2021 Financial Results on May 6, 2021

6.3 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021

6.4 Aug 06, 2020: Insulet to Announce Second Quarter 2020 Financial Results on August 6, 2020

6.5 Jun 15, 2020: MicroPort announces strategic investment and forms joint venture with Indian medical device company Purple Medical

6.6 Jun 09, 2020: Medtronic announces scientific data presentations at the American Diabetes Association 80th Scientific Sessions

7 Appendix

Companies Mentioned

• Andain, Inc
• Debiotech SA
• MedSolve Technologies, Inc.
• Qlibrium Inc
• SFC Fluidics LLC
• Thermalin Inc

For more information about this report visit https://www.researchandmarkets.com/r/50p2cc

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900